Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

and Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Who Will be Treated With Prophylactic Antibiotics Zinacef vs. Placebo

NCT06849037 is registered in ClinicalTrials.gov with Western Galilee Hospital-Nahariya as lead sponsor.

NCT NCT06849037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06849037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
and Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Who Will be Treated With Prophylactic Antibiotics Zinacef vs. Placebo
Lead sponsor
Western Galilee Hospital-Nahariya
Phase
Not applicable
Overall status
Recruiting
Start date
February 18, 2025
Completion date
February 13, 2028
Enrollment
182 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chorioamnionitis, meconium-stained amniotic fluid